SVETLANA L SABEL

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology WEST ORANGE, NJ NPI 1124307616

General Payments — all program years on this page

$1,336.94

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 63
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $557.67 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $557.6720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $125.2310
2020 $78.065
2021 $114.878
2022 $56.434
2023 $404.6816
2024 $557.6720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1094052185 Alexion Pharmaceuticals, Inc. $18.19 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097513454 Novo Nordisk Inc $14.44 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105923631 VERTEX PHARMACEUTICALS INCORPORATED $14.65 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123325495 Mirum Pharmaceuticals, Inc. $131.33 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123325497 Mirum Pharmaceuticals, Inc. $135.63 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127044279 Kyowa Kirin, Inc. $15.34 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127060287 BioMarin Pharmaceutical Inc. $23.64 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127062250 BioMarin Pharmaceutical Inc. $15.66 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133844462 Ascendis Pharma Inc $19.85 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133848441 Ascendis Pharma Inc $13.35 10/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134012013 Azurity Pharmaceuticals, Inc. $16.35 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134012015 Azurity Pharmaceuticals, Inc. $16.32 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134012017 Azurity Pharmaceuticals, Inc. $17.06 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136289843 Organon Llc $18.01 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136289847 Organon Llc $13.69 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137666250 Takeda Pharmaceuticals U.S.A., Inc. $15.39 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137666252 Takeda Pharmaceuticals U.S.A., Inc. $13.35 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138587200 Endo USA, Inc. $13.10 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147347007 Mylan Specialty L.P. $17.14 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150200291 JAZZ PHARMACEUTICALS INC. $15.18 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.